Communiqués BBS-Bioactive Bone Substitutes Oyj

Actions

BONEH

FI4000260583

Marché Fermé - Nasdaq Helsinki Autres places de cotation 18:00:00 28/06/2024			Varia. 5j.	Varia. 1 janv.
0,354 ^EUR	+0,57 %		+5,67 %	-27,61 %

13/06	BBS-Bioactive Bone Substitutes Oyj approuve l'élection de Gregor Siebert en tant que nouveau membre du conseil d'administration	CI
04/06	BBS-Bioactive Bone Substitutes Plc annonce l'approbation d'une demande de brevet complémentaire pour le produit ARTEBONE®.	CI

Communiqués

Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !

Inscription 100% Gratuite

BBS-Bioactive Bone Substitutes Plc: Notification pursuant to the Finnish Securities Market Act, Chapter 9, Section 10 - Municipality of Reisjärvi	19/06	AQ
BBS-Bioactive Bone Substitutes Plc: Notification pursuant to the Finnish Securities Market Act, Chapter 9, Section 10 - Finha Capital Oy	18/06	AQ
BBS-Bioactive Bone Substitutes Plc plans a share issue to strengthen its equity and will advance the publication date of its half-year report	18/06	AQ
BBS-Bioactive Bone Substitutes Plc: Notification pursuant to the Finnish Securities Market Act, Chapter 9, Section 10 - Panvest Oy	14/06	AQ
BBS-Bioactive Bone Substitutes Plc: Decisions of the Annual General Meeting 2024	13/06	AQ
BBS-Bioactive Bone Substitutes Plc: Conversion of convertible notes pursuant to financing arrangement between BBS and Riverfort Global Opportunities PCC Ltd	05/06	AQ
BBS-Bioactive Bone Substitutes Plc: Claims of the complementary patent application for the ARTEBONE® product have been approved in the USA	04/06	AQ
Notice to the BBS-Bioactive Bone Substitutes Plc’s Annual General Meeting	23/05	AQ
BBS-Bioactive Bone Substitutes Plc: Conversion of convertible notes pursuant to financing arrangement between BBS and Riverfort Global Opportunities PCC Ltd	21/05	AQ
BBS-Bioactive Bone Substitutes Plc: Annual General Meeting in 2024	07/05	AQ
BBS-Bioactive Bone Substitutes – Insider information: The company updates the status of the CE marking process	05/05	AQ
BBS-Bioactive Bone Substitutes Plc: Annastiina Kauppinen appointed as Financial Manager of BBS-Bioactive Bone Substitutes Plc	25/04	AQ
BBS-Bioactive Bone Substitutes Plc: Conversion of convertible notes pursuant to financing arrangement between BBS and Riverfort Global Opportunities PCC Ltd	24/04	AQ
BBS-Bioactive Bone Substitutes Plc: Annual General Meeting in 2024	17/04	AQ
BBS-Bioactive Bone Substitutes Plc: Conversion of convertible notes pursuant to financing arrangement between BBS and Riverfort Global Opportunities PCC Ltd	15/04	AQ
BBS-Bioactive Bone Substitutes Plc: The website's functionality restored	05/04	AQ
BBS-Bioactive Bone Substitutes Plc: Annual General Meeting in 2024	03/04	AQ
BBS-Bioactive Bone Substitutes Plc: The website is under attack	26/03	AQ
Correction: BBS-Bioactive Bone Substitutes Plc: Annual Report for 2023 has been published	13/03	AQ
BBS-Bioactive Bone Substitutes Plc: Annual Report for 2023 has been published	08/03	AQ

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués BBS-Bioactive Bone Substitutes Oyj

Actions

BONEH

FI4000260583

Communiqués

Filtres